Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,075.00
-13.00 (-1.19%)
Aug 12, 2026, 1:04 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 76.65 billion as of August 11, 2026. Its market cap has decreased by -65.08% in one year.
Market Cap
76.65B
Enterprise Value
132.07B
Revenue
43.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,075.00
ChartMarket Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 76.65B, a decrease of -67.68%. That is a compound annual growth rate of -8.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 75.03B | -24.17% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 120.07B |
| Vaxcell-Bio Therapeutics | 96.98B |
| MedPacto | 94.94B |
| iNtRON Biotechnology | 80.78B |
| Prestige BioPharma | 79.33B |
| CG Invites | 76.43B |
| ENCell | 68.05B |
| ORIENT BIO | 63.14B |